Tait, D., Diacon, A., Borges, Á.H., van Brakel, E., Hokey, D., Rutkowski, K.T., Hunt, D.J., Russell, M., Andersen, P.L., Kromann, I. and Ruhwald, M., 2024. Safety and Immunogenicity of the H56: IC31 Tuberculosis Vaccine Candidate in Adults Successfully Treated for Drug-Susceptible Pulmonary Tuberculosis: A Phase 1 Randomized Trial. The Journal of Infectious Diseases, p.jiae170.
Safety and immunogenicity of the H56:IC31 tuberculosis vaccine candidate in adults successfully treated for drug-susceptible pulmonary TB: a phase 1 randomized trial.
- Journal Articles
